Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury

Abstract

KAL protein is identified as the active agent in a therapeutic composition for treatment of injury to nerve tissue, including spinal cord tissue, as well as support of treatment for renal grafts. Additionally, therapeutic treatment of renal injury, and kidney transplantation and renal surgery, is effected by administration of KAL protein. The therapeutic agent may be administered locally, or intravenously. Retinal disorders may be similarly treated.

Dependencies are inferred from the claim text.